Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Spain
Verteporfin

AEMPS 2001

Verteporfin

Visudyne 15 MG Polvo Para Solucion Para Perfusion

15 mg polvo para solución para perfusiónSpainMarketedAuthorised 21 Feb 2001

Product informationAsk Osler about it

On this page

In other countries
Packs
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

VisudyneBrazil · Novartis Biociencias S.ASame brand
VisudyneCanada · 15 MG / VIAL · Powder For Solution · Cheplapharm Arzneimittel GMBHSame brand
VisudyneEuropean Union · CHEPLAPHARM Arzneimittel GmbHSame brand
VisudyneCroatiaSame brand
VisudyneItaly · Polvere per soluzione per infusione endovenosa · Cheplapharm Arzneimittel GMBHSame brand
Visudyne, poeder voor oplossing voor intraveneuze infusie 15 mgNetherlands · Poeder voor oplossing voor injectie · CHEPLAPHARM Arzneimittel GmbHSame brand
Visudyne 15MG Powder for InfusionSaudi Arabia · JHP PharmaceuticalsSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇸🇬VISUDYNE FOR INJECTION 15 mg/vialSingapore · 15 mg/vial · injection · Zuellig Pharma Pte. LTD.Same brand

🇺🇸VisudyneUnited States · 15MG/VIAL · injectable · Bausch Lomb IrelandSame brand

🇧🇷VerteporfirinaBrazil · Elanco Saude Animal LtdaSame substance

Packs

Pack	Code	Status
VISUDYNE 15 MG POLVO PARA SOLUCION PARA PERFUSION, 1 vial	909713

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS
Package leafletAEMPS
Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Verteporfin
Strength: 15 mg
Dosage form: polvo para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 21 Feb 2001
Registration: 00140001
Marketing authorisation holder: Cheplapharm Arzneimittel Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario